Adults aged 80 and over, as well as all residents in care homes for older adults, will become eligible for the NHS respiratory syncytial virus (RSV) vaccine from 1 April 2026, said NHS England (NHSE) and the UK Health Security Agency (UKHSA) yesterday.
The change follows updated advice from the Joint Committee on Vaccination and Immunisation (JCVI) and expands the existing programme, which has offered routine vaccination to people turning 75 since September 2024.
Related Article: Payment percentage for statutory branded medicines scheme drops to 16.5%
In a letter to those delivering the programme, Caroline Temmink, NHSE director of vaccination, and Dr Mary Ramsay, UKHSA director of public health programmes, said the expansion is intended to protect those at increased risk of RSV, and care home residents will be eligible regardless of age.
The vaccine used will continue to be Abrysvo, delivered as a single dose. The timing of the expansion is designed to allow co-administration with the spring 2026 Covid-19 vaccine campaign.
The JCVI has said the two vaccines can be safely administered together, although guidance states that RSV vaccination is not seasonal and should be offered year-round.
General practice providers will be expected to offer the vaccine to 100% of the eligible population, and arrangements should also be made to vaccinate new care home residents as they become eligible throughout the year, according to the guidance.
Related Article: Research review: a look at the latest clinical papers
Practices are advised to rotate stock to minimise waste and hold no more than two to four weeks’ worth of vaccine supply at any time.
Coverage data will be collected quarterly from participating GP practices via ImmForm, and an updated Patient Group Direction (PGD) template will be made available.
Clinical guidance is available in the RSV chapter of the Green Book, and updated training materials will be published on the RSV vaccination programme webpage.
Related Article: Advice for newly qualified prescribing pharmacists published by GPhC
Further information and implementation details are expected as part of the forthcoming 2026/27 GP contract update.
A version of this story first appeared on our sister publication Nursing in Practice.
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.